4
Changes in Ownership
Atea Pharmaceuticals, Inc. Filed Acc 0000950170-24-070965
President, CEO, and Chairman sold 1,006 shares at $4.00 ($4,024)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Sommadossi Jean-Pierre President, CEO, and Chairman | 2024-06-05 | Sale 10b5-1 | −1,006 | $4.00 | $4,024 | 5,923,994 | I |
| Open-market sales · 1,006 sh · avg $4.00 · $4,024 | |||||||
Loading xslF345X05/ownership.xml…